Brief: Synact Pharma Gets Proceeds Of SEK 80 Million Through Issue
Feb 5 (Reuters) - SynAct Pharma AB SYNACT.TE :
* CARRIES OUT DIRECTED NEW ISSUE AND GETS PROCEEDS OF SEK 80
MILLION THROUGH ISSUE
Source text for Eikon: ID:nWkr9dqZVP
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026